CivaTech Oncology® Receives FDA Approval for CivaSheet™ Brachytherapy Device

CivaTech Oncology® Receives FDA Approval for CivaSheet™ Brachytherapy Device RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–CivaTech Oncology, a medical device company dedicated to developing innovations in radiation therapy, announced today it has received FDA clearance on its groundbreaking bioabsorbable, planar radiation device. “For the first time, radiation oncologists will have a configurable planar LDR array that is…

Details

Best NeuroLaunch Mentor Award for Summer 2015

The sold-out Investor Demo Day event was the capstone to NeuroLaunch’s inaugural 3 month accelerator program for neuroscience startup companies. The portfolio companies in Batch #1 were given access to over 100 world-class NeuroLaunch Mentors and Partners as well as a specialized curriculum featuring over 30 expert speakers on essential topics for neuroscience startups.   TAMM Net’s Arthur Spalding accepted…

Details

Hypepotamus Interview

Atlanta’s medical device industry is never short of innovative ideas, but to succeed companies also need sufficient funding, strategy, and industry connections. TAMM Net, established in 2009 by Arthur Spalding, is a resource that specifically caters to those needs. The consulting firm conducts clinical trials, negotiates regulatory applications with the FDA, gains reimbursements, and helps companies to maximize their sales in…

Details

Atlanta Catheter Therapies Receives Grant through Qualifying Therapeutic Discovery Project

Atlanta Catheter Therapies Receives Grant through Qualifying Therapeutic Discovery Project Medical device company Atlanta Catheter Therapies, Inc. (ACT) has received a grant for almost $250,000 through the Qualifying Therapeutic Discovery Project (QTDP) under the Patient Protection and Affordable Care Act of 2010. A total of $1 billion has been allocated to support biomedical research by…

Details